Legal Nurse Consulting

BOSTON- The U.S. Attorney's office filed a complaint in January 2010 against Johnson & Johnson for violating the anti-kickback statute and False Claims Act. Allegedly, J & J paid kickbacks for five years to Omnicore Inc, a long term care pharmacy, to increase the number of elderly patients taking the antipsychotic Risperdal and several other medications. Omnicare, due to its contract with J & J, sent faxes to thousands of doctors asking them to switch their dementia patients to Risperdal. Between the years of 1999 though 2004, Johnson & Johnson's annual sales jumped from $100 million dollars to more than $280 million. The pharmacy's annual purchase of Risperdal rose to more than $100 million, according to the complaint filed. Risperdal is approved by the Food and Drug Administration to treat schizophrenia and bipolar disorder, it is not specifically approved to treat behavioral problems in elderly people with dementia. In fact, in 2005 the FDA required ...

Since July 30, 2009, companies have been facing lawsuits for distributing Toxic Chinese Drywall. These companies include Chinese based manufacturers, as well as importers, developers and builders, contractors, suppliers and others. There have been hundreds of cases reported involving property damage and health problems. As a Product Safety Specialist, it is important to be aware of the side effects and problems provoked by this product, especially when dealing with related cases in Florida, Louisiana, Alabama, Georgia and Virginia since these states have been impacted at the highest rate. Reports show that the Chinese drywall leaks corrosive chemicals that turn copper tubing black, causes the failure of air conditioning coils exposed to the drywall, causes corrotin on mirrors and fixtures, smells of sulfur, and causes respiratory problems, premature aging, nose bleeds, and headaches from airborne compounds. Florida Inspectors argue that homes built between 2000-2007 should be tested ...